Stago webinar: Disseminated intravascular coagulation (DIC) - An in-depth look for 2026
Clinicians, clinical pathologists, researchers, and clinical laboratory staff will have the opportunity to deepen their knowledge of the pathophysiology of Disseminated intravascular coagulation (DIC) and the newly published ISTH definition and scoring system.
Read more
Stago at WHX Labs Dubai 2026: Four days of innovation and networking
Stago teams from Saudi Arabia, Turkey, Dubai, and headquarters participated in WHX Labs Dubai 2026, formerly known as Medlab Middle East. Held at the Dubai World Trade Centre, the event brought together over 35,000 professionals from 180 countries.
Read more
Communication of March 4, 2026
Dear valued Partner,
We are pleased to share an important update regarding Stago's future.
Stago has entered into an exclusive negotiations with ARCHIMED, a healthcare-focused investment firm and La Caisse, also active in the healthcare sector, to support the next phase of our growth.
This step reflects a strategic decision to further strengthen Stago's long-term growth while preserving what has always defined us: scientific excellence, reliability, deep expertise in hemostasis, and a strong commitment to customer partnerships.
Stago webinar: Emerging biomarker for thrombotic risk stratification in coronary artery disease
Clinicians, clinical pathologists, researchers, and clinical laboratory staff will have the opportunity to deepen their knowledge of the role of TF-positive platelets in arterial thrombosis and CAD progression, as well as their potential to improve thrombotic risk stratification beyond traditional models.
Read more
Stago enters into exclusive negotiations with ARCHIMED and La Caisse
PRESS RELEASE: December 11, 2025
The Stago Group, a global leader in diagnostics and a specialist in hemostasis, announced today that it has entered into exclusive negotiations with a consortium led by ARCHIMED, an investment fund dedicated to the healthcare sector, with a view to acquiring a majority stake in the group. La Caisse (formerly Caisse de dépôt et Placement du Québec) would invest alongside ARCHIMED as a minority investor.
Read more
